HIGHFDA DRUG

Sandoz Cyclophosphamide Injection 500 mg/5 mL Recalled for Temperature Excursion During Transport

Sandoz Inc. recalled 263 vials of Cyclophosphamide injection distributed nationwide in the United States. The recall cites cGMP deviations due to a temperature excursion during transportation. Healthcare providers and patients should stop using the product and contact Sandoz for guidance.

Official notice
SandozHealth & Personal CareDrugs & MedicationsLot # 110459 exp. date 02/28/2027

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
September 5, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
September 5, 2025
Hazard Level
HIGH
Brand
Sandoz
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Sandoz
Product type
Hazardous drug injection
Model numbers
Lot # 110459 exp. date 02/28/2027
UPC codes
0781-3528, 0781-3529, 0781-3530, 0781-3528-75, 0781-3528-10, 0781-3529-70, 0781-3529-10, 0781-3530-80 +1 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    September 5, 2025

  2. Reported by FDA DRUG

    September 24, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

cGMP deviations: Temperature excursion during transportation.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Sandoz Inc or your healthcare provider for guidance. Notification method: Letter

About This Product

Cyclophosphamide is a chemotherapy agent used to treat various cancers. It is supplied in vials for hospital or clinic administration.

Industry Context

This recall is not described as part of a broader industry pattern in the notice.

Real-World Impact

Healthcare facilities must identify affected lots and replace or refund through the recall process. No injuries have been reported yet.

Practical Guidance

How to identify if yours is affected

  1. Verify lot number 110459 on the vial
  2. Check expiration date 02/28/2027
  3. Cross-check with the FDA recall notice D-0651-2025

Where to find product info

NDC numbers on vial and carton labeling; lot number on vial label

What timeline to expect

Remedy via letter; replacement or refund timelines will be communicated by Sandoz

If the manufacturer is unresponsive

  • Document communication attempts
  • Contact distributor or healthcare facility regulatory affairs office
  • File complaint with FDA if necessary

How to prevent similar issues

  • Ensure proper cold-chain handling for hazardous drugs
  • Verify lot and expiry during receipt
  • Maintain inventory logs for recalls

Documentation advice

Keep the recall notice, lot and NDC details, and correspondence with Sandoz for records

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers: Lot # 110459 exp. date 02/28/2027. Quantity: 263 vials. NDCs: Vial NDC 0781-3528-75, Carton NDC 0781-3528-10. Sold nationwide in the USA. Manufacturer: Fareva Unterach GmbH in Austria for Sandoz Inc., Princeton, NJ 08540. Product category: Cyclophosphamide injectable chemotherapy.

Reported Incidents

No injuries or incidents have been reported in the notice. The recall status remains ACTIVE.

Key Facts

  • 263 vials recalled nationwide
  • Lot # 110459 exp. date 02/28/2027

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANT
Injury Types
POISONINGOTHER

Product Details

Brand
Model Numbers
Lot # 110459 exp. date 02/28/2027
UPC Codes
0781-3528
0781-3529
0781-3530
+6 more
Affected States
ALL
Report Date
September 24, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more